Investigation of menstruation recovery after LH-RH agonist therapy for premenopausal patients with breast cancer.
- 1 August 2000
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 7 (3) , 237-240
- https://doi.org/10.1007/bf02967466
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VIEuropean Journal Of Cancer, 1998
- Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.Journal of Clinical Oncology, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Goserelin (Zoladex ) depot in the treatment of endometriosisFertility and Sterility, 1992
- Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosissHuman Reproduction, 1991
- Effect of LHRH agonist, Zoladex, on ovarian histologyBritish Journal of Surgery, 1988
- Shrinkage of uterine fibroids during therapy with goserelin (Zoladex ): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depotFertility and Sterility, 1987